Illumina, Inc.
ILMN
•Stock Analysis$94.79
+0.00 (+0.00%)• Live
Illumina, Inc. Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Illumina, Inc.
Key Financial Metrics
for Illumina, Inc.
P/E Ratio
-14.42
Revenue Growth
-2.93%
EPS Growth
-4.63%
Market Cap
$13.86B
Dividend Yield
0.00%
Debt/Equity
1.10
ROIC
+32.03%
FCF Yield
+6.27%
View additional metrics
Valuation
P/B Ratio5.88
EV/Sales3.54
Financial Health
Current Ratio1.86
Return on Assets-20.14%
Analyst Recommendations
for Illumina, Inc.
50 analysts
Consensus: Hold
About
for Illumina, Inc.
Company Details
for Illumina, Inc.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jacob Thaysen
Employees
8,970
Market Cap
15.01B
Exchange
NASDAQ Global Select
IPO Date
July 28, 2000
Website
www.illumina.comCIK
0001110803
ISIN
US4523271090
CUSIP
452327109
Country
US
Balance Sheet
for Illumina, Inc.
Cash Flow Statement
for Illumina, Inc.
Income Statement
for Illumina, Inc.
News
No news available at the moment.